Geron Corporation

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-70.2M
Depreciation & Amortization —
Depreciation $1.8M
Amortization —
Stock-Based Compensation $10.6M
Net Cash from Operating Activities $-43.4M
Investing Activities
Capital Expenditures $1.4M
Business Acquisitions —
Net Cash from Investing Activities $-83.0M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $51.6M
Net Change in Cash $-74.7M
Free Cash Flow $-44.8M
← Newer Page 3 of 3 Older →